Behcet'
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with Behçet’s disease during 1/1/2008 – 31/7/2018
Exclusion criteria
Exclusion criteria: 1.Inconsistent with the diagnostic criteria for Behçet’s disease (1990 ISG* or 2014 ICBD**criteria) 2.Incomplete medical records *1990 The International Study Group for Behçet’s disease (ISG) criteria **2014 The International Criteria for Behçet’s Disease (ICBD)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the associations between cutaneous manifestations and Behçet’s disease severity 96 months 2006 Behcet's Disease Current Activity Form (BDCAF) | — |
Secondary
| Measure | Time frame |
|---|---|
| cutaneous manifestations as prognostic indicators of Behçet’s disease 96 months Cumulative dose of corticosteroids, morbidity, and mortality | — |
Countries
Thailand
Contacts
Division of Dermatology, Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital,